More on IRD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $5.41 |
|
|||
| Open | $5.46 | ||||
| 52 Wk High | $0.02 | ||||
| 52 Wk Low | $0.02 | ||||
| Day High | $5.62 | ||||
| Day Low | $5.42 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 281,261 | ||||
- Form 4 Opus Genetics, Inc. For: Sep 09 Filed by: Magrath George
- Form 8-K Opus Genetics, Inc. For: Sep 11
- Big Pharma Setbacks Create a New Wave of Rebound Plays
- Opus Genetics (IRD) PT Raised to $17 at Citizens
- Opus Genetics (IRD) PT Raised to $13 at Wedbush
- Four Biotech Stories Heating Up Right Now
- Opus Genetics reports early positive data from gene therapy eye trial
- H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
- Opus Genetics (IRD) Reiterated at Market Outperform by Citizens: Focus on Viatris
- Longeveron names Nirav Jhaveri as CFO
Entities mentioned with IRD
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
